Article
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma
9 Jan 2025
Abstract excerpt
Human tumors are diverse in their natural history and response to treatment, which in part results from genetic and transcriptomic heterogeneity. In clinical practice, single-site needle biopsies are used to sample this diversity, but cancer biomarkers may be confounded by spatiogenomic heterogeneity within individual tumors. Here we investigate clonally expressed genes as a solution to the sampling bias problem...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
